2 completed, 1 recruiting, 1 unknown. 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Factor XIII: new trials by email Literature Review of Factor XIII trials Research Report on Factor XIII
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SWIFT - SWIss Factor XIII Trial in PPH Fibrogammin - Postpartum Hemorrhage, Coagulation Disorder | Phase 4 | Recruiting | Christian Haslinger | 988 | 2024-07-09 | 2026-04-27 |
| Factor XIII Activity in Gastrointestinal Bleedings Factor XIII Injection - Gastro Intestinal Bleeding | Completed | Medical University of Graz | 97 | 2021-01-08 | 2025-03-25 | |
| CSL Behring Sclero XIII Fibrogammin®P, coagulation factor XIII concentrate (Human), 0.9% sodium chloride - Systemic Sclerosis | Phase 2 | Unknown | University College, London | 26 | 2015-09-01 | 2016-05-30 |
| An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency FXIII Concentrate (Human) (FXIII) - Factor XIII Deficiency | Phase 3 | Completed | CSL Behring | 61 | 2009-09-01 | 2012-10-12 |
Factor XIII Deficiency (1) · Gastrointestinal Hemorrhage (1) · Hemorrhage (1) · Hemostatic Disorders (1) · Postpartum Hemorrhage (1) · Raynaud Disease (1) · Scleroderma, Systemic (1) · digital ulcers (1)
CSL Behring (1) · Christian Haslinger (1) · Medical University of Graz (1) · University College, London (1)
Austria (1) · Switzerland (1) · United Kingdom (1) · United States (1)
Beatrice Mosimann, Prof. Dr. (1) · Christian Haslinger, Prof. Dr. (1) · Christoph Hoegenauer, Prof. (1) · Christopher Denton, PhD (1) · Jarmila Zdanowicz, MD (1) · Leila Sultan-Beyer, MD (1) · Michael Winter, MD (1) · Sara de Oliveira, MD (1) · Tina Fischer, MD (1)
PMID 32176833, PMID 40345697, PMID 41472522
2014 (1)